Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Association of Increase of NETosis and Nucleosome Biomarkers measured by Nu.Q® NETs with Mortality in Septic Shock

Wednesday, October 25, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The poster presented by Rahimi et al. at ESICM 2023 discusses the association of increased NETosis and nucleosome biomarkers, as measured by the Nu.Q® NETs assay, with mortality in septic shock patients. This research highlights the potential prognostic value of the Nu.Q® cancer test in understanding sepsis-related outcomes. The findings may contribute to improved patient management in critical care settings.
Price reaction · baseline $16.9 (2023-10-25T14:49:00.000Z) · hit during market hours · 2 other VNRX headline(s) in the window, move may be shared
day 0 close · peak
-4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Presentation at a significant conference (ESICM 2023).
  • Potential prognostic value of Nu.Q® NETs assay in septic shock.
  • Connection established between NETosis and mortality.

Full Press Release Details

Poster title: Association of Increase of NETosis and Nucleosome Biomarkers measured by Nu.Q® NETs assay with Mortality in Septic Shock
Presented at: ESICM 2023
Rahimi et al

Related Articles

• Press Releases Data Showing the Prognostic Value of its Nu.Q® Cancer Test
• Poster & Publications Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

Data Showing the Prognostic Value of its Nu.Q® Cancer Test

Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the focus of the presented poster?

The poster focuses on the association of NETosis and nucleosome biomarkers with mortality in septic shock.

Where was the research presented?

The research was presented at the ESICM 2023 conference.

What assay was used in the study?

The study utilized the Nu.Q® NETs assay to measure biomarkers.

Who conducted the research?

The research was conducted by Rahimi et al.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare Nu.Q® NETs septic shock mortality biomarkers ESICM 2023
Last updated: Oct 25, 2023

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk